Tandem Diabetes Care (TNDM) Revenue Growth (1y) (2014 - 2026)
Tandem Diabetes Care (TNDM) Revenue Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | 6.08% |
| 10 | Tandem Diabetes Care | 1.13 Bn | 562.40 Mn | 136.79 Mn | 5.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.46% |
| Dec 31, 2025 | 2.74% |
| Sep 30, 2025 | 2.17% |
| Jun 30, 2025 | 8.46% |
| Mar 31, 2025 | 22.30% |
| Dec 31, 2024 | 43.62% |
| Sep 30, 2024 | 31.43% |
| Jun 30, 2024 | 13.27% |
| Mar 31, 2024 | 13.16% |
| Dec 31, 2023 | -10.75% |
| Sep 30, 2023 | -9.25% |
| Jun 30, 2023 | -2.17% |
| Mar 31, 2023 | -3.71% |
| Dec 31, 2022 | 5.00% |
| Sep 30, 2022 | 13.87% |
| Jun 30, 2022 | 16.34% |
| Mar 31, 2022 | 24.72% |
| Dec 31, 2021 | 24.95% |
| Sep 30, 2021 | 45.33% |
| Jun 30, 2021 | 57.58% |